Greenfield Seitz Capital Management’s Novo Nordisk NVO Stock Holding History

Greenfield Seitz Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.42M	Buy	120,379 +20,001	+20%	+$948K	1.33%	28
2025 Q4	$5.11M	Buy	100,378 +3,418	+4%	+$175K	1.68%	20
2025 Q3	$5.38M	Buy	96,960 +12,948	+15%	+$758K	1.73%	20
2025 Q2	$5.8M	Buy	84,012 +5,362	+7%	+$365K	2.05%	16
2025 Q1	$5.46M	Buy	78,650 +3,100	+4%	+$256K	2.08%	17
2024 Q4	$6.5M	Buy	75,550 +10,288	+16%	+$1.11M	2.47%	11
2024 Q3	$7.77M	Sell	65,262 -1,650	-2%	-$220K	2.85%	8
2024 Q2	$9.55M	Sell	66,912 -2,923	-4%	-$387K	3.54%	4
2024 Q1	$8.97M	Sell	69,835 -2,688	-4%	-$320K	3.34%	5
2023 Q4	$7.5M	Buy	+72,523	New	+$7.17M	2.99%	6

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Greenfield Seitz Capital Management's NVO Position: Q1 2026 in Review

Greenfield Seitz Capital Management increased its Novo Nordisk (NVO) stake by 20% in Q1 2026, buying an estimated $948K and bringing the position to 120,379 shares worth $4.42M. The position accounts for 1.33% of the portfolio, ranked #28.

Greenfield Seitz Capital Management first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $9.55M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Greenfield Seitz Capital Management held 120,379 shares of Novo Nordisk worth $4.42M as of Q1 2026.
Greenfield Seitz Capital Management bought 20,001 Novo Nordisk shares in Q1 2026, an estimated $948K.
Novo Nordisk made up 1.33% of Greenfield Seitz Capital Management's portfolio in Q1 2026, its #28 holding.
Greenfield Seitz Capital Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
Greenfield Seitz Capital Management's Novo Nordisk position peaked at $9.55M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.